ArticleJournal of clinical medicine2023
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
Agustín Sancho-Saldaña et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.